FactaeThe Factual News

US approves new ADHD drug, but it remains unavailable in France

Centanafadine, a new ADHD drug, has been approved in the United States.

Published 2h1 sourceNotable
Lire en français
≈ 18s

The fact

The treatment offers a different mechanism of action from current options.

In France, patients cannot access it due to regulatory restrictions.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
États-UnisWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on August 7, 2026
← Back to home
Discover

Read more

All sante →
sante

The United States approves a new treatment for ADHD

3j · 1 sourceeconomie

Forty percent of new drugs unavailable in France, says Moderna CEO

6sem · 1 sourcesante

ADHD: Overdiagnosis Poses Risks of Overtreatment

11sem · 1 sourcemarches

Abivax receives positive feedback from FDA for obefazimod treatment

1sem · 1 sourcesante

ADHD Diagnosis in Adulthood: French Man's Account of Late Discovery

12sem · 1 sourcesante

Alcohol addiction: new treatments now available

2sem · 1 source